Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Asset Writedowns and Impairment (2017 - 2025)

Historic Asset Writedowns and Impairment for Dentsply Sirona (XRAY) over the last 8 years, with Q3 2025 value amounting to $9.0 million.

  • Dentsply Sirona's Asset Writedowns and Impairment fell 9821.43% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $323.0 million, marking a year-over-year increase of 4748.86%. This contributed to the annual value of $241.0 million for FY2024, which is 140625.0% up from last year.
  • According to the latest figures from Q3 2025, Dentsply Sirona's Asset Writedowns and Impairment is $9.0 million, which was down 9821.43% from $79.0 million recorded in Q2 2025.
  • Over the past 5 years, Dentsply Sirona's Asset Writedowns and Impairment peaked at $504.0 million during Q3 2024, and registered a low of -$291.0 million during Q4 2023.
  • Over the past 4 years, Dentsply Sirona's median Asset Writedowns and Impairment value was $9.0 million (recorded in 2025), while the average stood at $95.4 million.
  • Per our database at Business Quant, Dentsply Sirona's Asset Writedowns and Impairment plummeted by 495000.0% in 2023 and then surged by 18075.6% in 2024.
  • Over the past 4 years, Dentsply Sirona's Asset Writedowns and Impairment (Quarter) stood at $6.0 million in 2022, then tumbled by 4950.0% to -$291.0 million in 2023, then surged by 180.76% to $235.0 million in 2024, then plummeted by 96.17% to $9.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $9.0 million for Q3 2025, versus $79.0 million for Q2 2025 and $235.0 million for Q4 2024.